811. A Randomized Controlled Trial of Prednisolone vs. Interleukin 17 A Inhibitor Secuinumab in the Management of Type 1 Lepra Reaction in Leprosy Patients
Sign Up to like & getrecommendations! Published in 2018 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofy210.818
Abstract: Abstract Background Leprosy is a chronic granulomatous infectious disease caused by Mycobacterium leprae. Type 1 lepra reactions (T1R) are delayed hypersensitivity (Type IV) reactions which if not treated promptly leads to disability affecting eyes, hands… read more here.
Keywords: lepra reaction; prednisolone; reaction; type lepra ... See more keywords
Trigger of Type 2 Lepra reaction with acute foot drop following Covid‐19 vaccination
Sign Up to like & getrecommendations! Published in 2022 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.17915
Abstract: ‘COVID arm’ – histological features of a delayed-type hypersensitivity reaction to Moderna mRNA-1273 SARS-CoV2 vaccine. J Eur Acad Dermatol Venereol 2021; 35: e730–e732. 4 Kempf W, Kettelhack N, Kind F, Courvoisier S, Galambos J, Pfaltz… read more here.
Keywords: acad dermatol; type lepra; vaccination; reaction ... See more keywords